Biotech Stock News (ARWR) (GILD) (HRTX) (VRTX)

Arrowhead Research (NASDAQ:ARWR) On September 24, 2015 shares of Arrowhead were up as much as 20% after announcing positive phase 2a trial results for its Hepatitis B trial. Investors thought the results were good which is why the stock ended the day on the positive side. In addition to obtaining positive phase 2a Hep B … Read more

Biotech Stock News (IMGN) (RGLS) (GILD) (ACHN) (OPK) (BRLI)

Immunogen (NASDAQ:IMGN) Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy … Read more